Impact Biomedical INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
AMEX
Impact BioMedical Inc. has filed an amendment to its Form S-1 registration statement with the SEC, primarily to update information regarding the expenses associated with the issuance and distribution of securities.
AMEX
S-1/A: Impact BioMedical Files Amendment No. 6 to Form S-1, Outlines Common Stock Purchase Warrant Details
Impact BioMedical's latest S-1/A filing details the terms and conditions of a common stock purchase warrant issued to Revere Securities, LLC.
AMEX
Impact BioMedical Inc. has filed an amendment to its Form S-1 registration statement related to its proposed initial public offering of common stock and representative warrants.
AMEX
S-1/A: Impact BioMedical Inc. Files Amendment No. 4 to Form S-1, Preparing for Potential Public Offering
Impact BioMedical Inc. has filed an amendment to its Form S-1 registration statement, outlining details of a proposed initial public offering and related agreements.
AMEX
Impact BioMedical Inc. plans to raise approximately $7 million through an initial public offering of 2,000,000 shares of common stock.